Search

everythinglearnresearchcommunity

for

Search:↓

The protein CTCF is essential for skin development, maintaining hair follicles, and preventing inflammation.

Higher levels of certain DNAs in blood may indicate hair follicle damage in alopecia areata patients.

In late pregnancy, allopregnanolone reduces stress responses in rats by affecting brain chemicals.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Blocking the Mitochondrial Pyruvate Carrier causes stress in hair follicles, which can be reduced by an ISR inhibitor.

Live imaging helps us understand skin immune responses and develop treatments.

UVB radiation harms hair growth and health, causing cell death and other changes in human hair follicles.

Anti-IL-1 treatments might help with certain types of hair loss in people with high inflammation.

Mouse hair cells respond to male hormones by growing less, and this can be stopped by certain blockers.

Organoids can help study COVID-19 and develop treatments, but face challenges like instability and limited renewal.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

Lipopolysaccharides boost wheat seedling growth, but procyanidin B2 weakens this effect.

NDP-MSH protects brain cells and reduces inflammation in Parkinson's disease by activating MC1R and involving Tregs.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

PINK1 is important for controlling gut immune responses linked to early Parkinson's disease.

More research is needed to understand and manage rheumatoid arthritis better.

Jagged-1 in skin Tregs is crucial for timely wound healing by recruiting specific immune cells.

Plant roots respond to fungus smells by possibly using certain proteins and a plant hormone to change root growth, but more research is needed.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

Immune cells and cytokines significantly affect pathological scar development.

Tailored combination therapy improves non-scarring alopecia outcomes.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

Skin fat helps with body temperature control and has other active roles in health.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

A new mix of anthralin and calcipotriene might help treat severe hair loss.